Northwest Biotherapeutics reported $32.94M in Debt for its fiscal quarter ending in September of 2023.





Debt Change Date
Agenus USD 35.54M 2.34M Mar/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Celldex Therapeutics USD 2.34M 285K Dec/2025
Eisai JPY 236.67B 49.14B Sep/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
Merck USD 49.34B 7.97B Dec/2025
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 63.73B 231M Mar/2026
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025